Table 1 Properties of the prostate cancer patient cohort.
From: Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
Total number of patients | 90 | |||
Patients with PSA recurrence | 40 | |||
Gleason score Number of patients | 6 49 | 7a 31 | 7b 10 | |
Stage pT Number of patients | 2a 13 | 2b 1 | 2c 76 | |
Patient age (>=75y) Number of patients | 40–55 y 12 | 56–65 y 39 | 66–75 y 39 | |
Disease-free survival time (for non-censored patients) | mean 25.8 months | median 31.5 months | ||
Overall follow-up period | 2–118 months | |||
